‘Unvaccinated’ people in Kathmandu valley have developed antibodies against novel coronavirus: NHRC report
Photo: Xinhua
Kathmandu, October 8. A team of researchers at the Nepal Health Research Council have discovered that the Chinese anti-covid vaccine “VeroCell” was 9 percent more effective in Kathmandu valley, than the indian “Covishield” vaccine.
A detailed comparative analysis of antibodies in blood samples from 1,796 residents of Kathmandu valley, indicated that those who received the VeroCell vaccine produced an average of 72.4 percent antibody against the novel coronavirus.
On the other hand, the number was 63.3 percent for Covishield receivers.
Senior research officer of NHRC, Dr. Megha Nath Dhimal said that the difference can be overlooked because the time of administration of the two vaccines was not the same for all of the respondents.
“Both vaccines should be assumed to be equally effective,” Dhimal said.
The research also revealed that 46 percent of the unvaccinated and uninfected population had antibodies towards the lethal virus. Executive Director of NHRC Dr Gyawali described the cause of the phenomenon as “community-transmitted undetected infection.”
Facebook Comment
Related News
latest Video
Trending News
- This Week
- This Month
